Money · Lobbying reports · 119th Congress
H.R. 4709
10 saved lobbying reports name H.R. 4709.
10 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 9:39 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| REVVITY, INC. | REVVITY, INC. | $40,000.00reported as expenses | April to June 2026 | Open the report |
| GRIDIRON PUBLIC AFFAIRS, LLC | BEREN THERAPEUTICS | The report gives no amount | April to June 2026 | Open the report |
| EVERYLIFE FOUNDATION FOR RARE DISEASES | EVERYLIFE FOUNDATION FOR RARE DISEASES | $40,000.00reported as expenses | April to June 2026 | Open the report |
| THE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION | NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION | $140,000.00reported as expenses | April to June 2026 | Open the report |
| RED+BLUE STRATEGIES | GENEDX, LLC | $80,000.00reported as income | April to June 2026 | Open the report |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $140,000.00reported as expenses | April to June 2026 | Open the report |
| KING & SPALDING LLP | AMERICAN COLLEGE OF MEDICAL GENETICS | $20,000.00reported as income | April to June 2026 | Open the report |
| STEALTH BIOTHERAPEUTICS INC. | STEALTH BIOTHERAPEUTICS INC. | $120,000.00reported as expenses | April to June 2026 | Open the report |
| MASON CONSULTING, LLC | NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS | $24,000.00reported as income | April to June 2026 | Open the report |
| AMERICAN ACADEMY OF PEDIATRICS | AMERICAN ACADEMY OF PEDIATRICS | $789,257.00reported as expenses | April to June 2026 | Open the report |